Loading...
HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons
OBJECTIVE: Experimental studies suggested that HMG-CoA reductase inhibitors (‘statins’) may have antilymphoma properties. We investigated whether statin use is associated with reduced risk of non-Hodgkin lymphoma (NHL) in HIV-positive persons. DESIGN: A nested case–control study was conducted among...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846691/ https://ncbi.nlm.nih.gov/pubmed/21681055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e328349c67a |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|